ArticlePharmaceutical research2012
Utilizing the estrogen receptor ligand-binding domain for controlled protein translocation to the insoluble fraction.
James R Davis et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it